317 related articles for article (PubMed ID: 35611213)
81. Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin.
Liu D; Li J; Pan H; He F; Liu Z; Wu Q; Bai C; Yu S; Yang X
Sci Rep; 2016 Jun; 6():28796. PubMed ID: 27350323
[TBL] [Abstract][Full Text] [Related]
82. Nanostructured lipid carriers for intraocular brimonidine localisation: development, in-vitro and in-vivo evaluation.
El-Salamouni NS; Farid RM; El-Kamel AH; El-Gamal SS
J Microencapsul; 2018 Jan; 35(1):102-113. PubMed ID: 29310481
[TBL] [Abstract][Full Text] [Related]
83. Metronidazole-loaded nanostructured lipid carriers to improve skin deposition and retention in the treatment of rosacea.
Shinde UA; Parmar SJ; Easwaran S
Drug Dev Ind Pharm; 2019 Jul; 45(7):1039-1051. PubMed ID: 30727789
[TBL] [Abstract][Full Text] [Related]
84. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
85. Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer.
Imran M; Iqubal MK; Imtiyaz K; Saleem S; Mittal S; Rizvi MMA; Ali J; Baboota S
Int J Pharm; 2020 Sep; 587():119705. PubMed ID: 32738456
[TBL] [Abstract][Full Text] [Related]
86. RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells.
Lee SG; Kim CH; Sung SW; Lee ES; Goh MS; Yoon HY; Kang MJ; Lee S; Choi YW
Int J Nanomedicine; 2018; 13():3263-3278. PubMed ID: 29910614
[TBL] [Abstract][Full Text] [Related]
87. pH-sensitive PEGylation of RIPL peptide-conjugated nanostructured lipid carriers: design and in vitro evaluation.
Kim CH; Sa CK; Goh MS; Lee ES; Kang TH; Yoon HY; Battogtokh G; Ko YT; Choi YW
Int J Nanomedicine; 2018; 13():6661-6675. PubMed ID: 30425481
[TBL] [Abstract][Full Text] [Related]
88. Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box-Behnken design.
Emami J; Rezazadeh M; Sadeghi H; Khadivar K
Pharm Dev Technol; 2017 May; 22(3):370-382. PubMed ID: 27689412
[TBL] [Abstract][Full Text] [Related]
89. Enhanced Oral Absorption of Amisulpride Via a Nanostructured Lipid Carrier-Based Capsules: Development, Optimization Applying the Desirability Function Approach and In Vivo Pharmacokinetic Study.
El Assasy AEI; Younes NF; Makhlouf AIA
AAPS PharmSciTech; 2019 Jan; 20(2):82. PubMed ID: 30652198
[TBL] [Abstract][Full Text] [Related]
90. Novel Strategies against Cancer: Dexibuprofen-Loaded Nanostructured Lipid Carriers.
Thiruchenthooran V; Świtalska M; Bonilla L; Espina M; García ML; Wietrzyk J; Sánchez-López E; Gliszczyńska A
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232614
[TBL] [Abstract][Full Text] [Related]
91. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
Pradhan M; Singh D; Murthy SN; Singh MR
Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018
[TBL] [Abstract][Full Text] [Related]
92. Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against
Tian B; Yan Q; Wang J; Ding C; Sai S
Int J Nanomedicine; 2017; 12():7131-7141. PubMed ID: 29026306
[No Abstract] [Full Text] [Related]
93. Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain.
Salunkhe SS; Bhatia NM; Bhatia MS
Drug Deliv; 2016 May; 23(4):1306-16. PubMed ID: 25080227
[TBL] [Abstract][Full Text] [Related]
94. Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer's Disease in Rat Model.
Shehata MK; Ismail AA; Kamel MA
Int J Nanomedicine; 2023; 18():4193-4227. PubMed ID: 37534058
[TBL] [Abstract][Full Text] [Related]
95. Preparation, characterization, and
Saghafi Z; Mohammadi M; Mahboobian MM; Derakhshandeh K
Drug Dev Ind Pharm; 2021 Mar; 47(3):509-520. PubMed ID: 33650445
[TBL] [Abstract][Full Text] [Related]
96. Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy.
Alam T; Pandit J; Vohora D; Aqil M; Ali A; Sultana Y
Expert Opin Drug Deliv; 2015 Feb; 12(2):181-94. PubMed ID: 25164097
[TBL] [Abstract][Full Text] [Related]
97. Nanostructured lipid carriers incorporating prickly pear seed oil for the encapsulation of vitamin A.
AlZahabi S; Sakr OS; Ramadan AA
J Cosmet Dermatol; 2019 Dec; 18(6):1875-1884. PubMed ID: 30784168
[TBL] [Abstract][Full Text] [Related]
98. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
[TBL] [Abstract][Full Text] [Related]
99. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
Fu T; Yi J; Lv S; Zhang B
J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
[TBL] [Abstract][Full Text] [Related]
100. Design and dermatokinetic evaluation of Apremilast loaded nanostructured lipid carriers embedded gel for topical delivery: A potential approach for improved permeation and prolong skin deposition.
Rapalli VK; Sharma S; Roy A; Singhvi G
Colloids Surf B Biointerfaces; 2021 Oct; 206():111945. PubMed ID: 34216849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]